Chemosensitivity assay using tumor cells that exhibit phenotypic characteristics of resistance

摘要

Assay system described herein, methods, means and represent a uniform improved system for monitoring the progression of malignancy in an individual patient. For screening for the identification and monitoring of secretory markers and cell markers, cell phenotype and to detect genotypic drift, systems and assays described herein, methods and means, at least representing for predicting chemotherapy responses of tumor cells of the patient to the therapeutic agent or agents, a uniform system that is improved. The system assay as described herein, methods and means, to represent a unified improved system for screening and monitoring efficacy and for long-term effect on a particular patient, and several drugs.